Skip to content

Osterebro

Active Private limited companyfounded 2013active for 13 yearsVredelaan 3, 2350 VosselaarKBO/BCE: BE 0540.971.572

Lifetime

12 annual accounts with figures on one time axis
peak of €401,576 in 2025
€401,576▲ 2.4%
peak of €295,109 in 2025
€295,109▲ 1.8%
peak of €418,991 in 2017
€313,709▲ 1.1%
€75,629▼ 20.5%
Board1 name since 2013
1 director
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Dividend €291,799Debts from €95,182 to €75,629

Key points

from the 2025 annual accounts

Equity

€313,709 ▲ 1.1%
310,3992024+295,109Profit-291,799Dividend313,7092025

Osterebro paid out €291,799 in dividends. That is 99% of the 2025 profit.

Turnover

≈ €810,000 estimated

The micro format states no turnover.

Filings

12 annual accounts since 2014
AprilJune31 JulyOctober201520202025

The 2017 accounts came 6 days late. The other nine of the last ten were filed on time.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,728 companies had the same profile as Osterebro has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,728 companies, not a prediction for Osterebro. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 17-10-2013
  • partner and founderdeed of 30-10-2013
Board & ownership

Recent changes

Company renamed from Dr. to Osterebro changes role from manager to director · Discharge granted to (manager) · Gazette deed
Registered office moved from Zoersel to Vosselaar The registered office moved from De Hulsten 76, 2980 Zoersel to Vredelaan 3, 2350 Vosselaar · General meeting of 05-02-2018 · Gazette deed
Registered office moved from Edegem to Zoersel The registered office moved from Drie Eikenstraat 370, 3650 Edegem to De Hulsten 76, 2980 Zoersel · Gazette deed
First establishment Dr. , Drie Eikenstraat 370, Edegem
All 23 events

Official details

Source: KBO
Status
Active since 17-10-2013Normal situation
Activity
Specialist medical practiceNACE 862201 activity on the establishment unitFrom the articles, 10 activities
Establishment unit
2.223.866.8372650 Edegem, since 21-10-2013
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€389,338▼ 4.0%
Filing
Filed on 30-06-2026, 31 days before the end of the filing period
Financials

Insights on Osterebro

Osterebro files the micro format. That format states no turnover. The gross margin rose from €81,297 in 2014 to €401,576 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Osterebro

What is the company number of Osterebro?
The company number of Osterebro is 0540.971.572. The VAT number is the same number with BE in front: BE 0540.971.572.
Where is Osterebro based?
The registered office is at Vredelaan 3, 2350 Vosselaar.Company details
What does Osterebro do?
According to the KBO register, the main activity of the establishment unit is specialist medical practice (NACE 86220).
What is the legal form of Osterebro?
Osterebro is a private limited company (BV).
When was Osterebro founded?
Osterebro was founded on 17-10-2013.
Is Osterebro still active?
Yes, Osterebro is an active enterprise in the KBO register.
What is the turnover of Osterebro?
The turnover in financial year 2025 is about €810,000. This figure is estimated from the gross margin of €401,576 and 1,018 comparable companies of the same size. It probably lies between €560,000 and €1.2m. It is a rough estimate.Financials
Is Osterebro profitable?
In financial year 2025, Osterebro made a profit of €295,109.
Where can I find the annual accounts of Osterebro?
Osterebro filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Osterebro due?
Osterebro must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.